Device Technologies has been informed by Intuitive Surgical Sarl (Intuitive) of a cybersecurity incident involving unauthorised access to information within one of Intuitive’s internal IT business applications following a targeted phishing attack.

Device Technologies has announced the official inclusion of the Bentley BeFlared Stent Graft System, on the Australian Register of Therapeutic Goods (ARTG) (ARTG 523842), a major milestone in the treatment of complex aortic aneurysms.

St Vincent’s Private Hospital Sydney has become the first medical institution in NSW to install and implement the da Vinci SP*, the latest in robotic surgery technology, in order to improve patient outcomes and support surgical professionals.

Device Technologies has announced the official inclusion of Intuitive’s most advanced and integrated robotic-assisted surgical system, da Vinci 5*, on the Australian Register of Therapeutic Goods (ARTG) (ARTG 97348), marking a major leap forward in the evolution of minimally invasive surgery.

Device Technologies has announced the official inclusion of Route 92 Medical’s pioneering FreeClimb® system on the Australian Register of Therapeutic Goods (ARTG) (ARTG 515885, 516066 and 516067), making the innovative neurovascular intervention technology widely accessible across the country.

In today’s fast-paced healthcare environment, efficiency and accessibility are crucial for clinical teams, particularly in Gastroenterology. As a rapidly expanding specialty within the Australian and New Zealand healthcare systems, teams consistently experience high demand for gastroenterology care, with specialists, nurses, and allied health teams managing substantial patient volumes each day. At Device Technologies, our Gastroenterology team understands this best; each moment made more efficient is more time spent with patients, helping improve their outcomes.

Device Technologies has been awarded the 2025 Kerrin Rennie Award for excellence in medical technology.

Japan Lifeline Co. Ltd (JLL), a leading Japanese medical device company specialising in cardiology and cardiovascular surgery fields, has taken a significant step in appointing Device Technologies as their exclusive distributor in Australia and New Zealand, as they expand their presence into one of the region’s most significant healthcare markets.

With over 120 years of combined experience, our Infection Prevention team is passionate about protecting the health and safety of both healthcare professionals and their patients across the regions.

Device Technologies has announced the appointment of Heath Priestly as Chief Executive Officer, succeeding Michael Trevaskis, who will transition to the role of Executive Vice Chairman.

Device Technologies is proud to announce it has been awarded the APAC 2025 Enterprise B2B eCommerce Distributor of the Year for its customer website, Device Online.

Device Technologies has announced the installation of a significant piece of surgical technology at Royal North Shore Public Hospital, marking a major step forward in equitable access for public patients across the North Shore, Northern Beaches and s